Illumina (ILMN -0.8%) postphones its Q4 and year-end earnings releases - saying that it's...

|By:, SA News Editor

Illumina (ILMN -0.8%) postphones its Q4 and year-end earnings releases - saying that it's focused on taking a formal position on the Roche (RHHBY.PK) takeover attempt within ten business days. ILMN trades at $52.24 - pricing in an expectation of a better offer than Roche's $44.50 per share somewhere down the road.